http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112028980-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43586 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 |
| filingDate | 2020-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112028980-B |
| titleOfInvention | Sericin, extraction method, application of sericin as cellular antiviral immunopotentiator and application of sericin |
| abstract | The invention belongs to the technical field of extraction of natural protein components and virology, and discloses sericin, an extraction method, application of the sericin as a cellular antiviral immunopotentiator and application of the sericin, and application of the sericin in preparation of a medicament for preventing and controlling viral infection; the dose concentration of sericin is 10-20mg/mL, and the effective final concentration is more than or equal to 1 mg/mL; the extraction method of sericin comprises the following steps: selecting available silkworm cocoons and storage conditions, pretreating and sterilizing the silkworm cocoons, dissolving sericin, dialyzing, renaturing sericin, concentrating a sericin solution, removing endotoxin in the sericin solution, filtering the sericin solution, controlling and detecting the quality of the sericin solution, and taking the sericin solution which meets the detection standard as a cellular antiviral immunopotentiator. The invention develops and utilizes the fibroin sericin for the first time, and the fibroin sericin is used for preventing and controlling the virus infection. The invention has wide raw material sources, and low cost compared with the high synthesis and production cost of other antiviral medicaments. |
| priorityDate | 2020-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.